Statins lower LDL concentrations by inhibiting the rate-limiting enzyme in cholesterol biosynthesis, HMG-CoA reductase, thereby attenuating atherosclerosis and are widely recommended as first-line treatment for diagnosed atherosclerosis [74,75]. The gene discussed is HMGCR; the disease is atherosclerosis.